In situations where supplies are limited, the National Institutes of Health’s COVID-19 Treatment Guidelines Panel today recommended prioritizing remdesivir for use in hospitalized patients with COVID-19 who require supplemental oxygen but are not mechanically ventilated or on extracorporeal membrane oxygenation. The panel expects to release additional updates to its recommendations for use of remdesivir soon.

Related News Articles

Headline
Proactive COVID-19 testing of all long-term care staff and residents, who are usually at higher risk of contracting the virus, may help prevent potential…
Headline
The Food and Drug Administration yesterday approved a new drug application for propofol injectable emulsion, an intravenous general anesthetic and sedation…
Headline
In a sample of 598 hospitalized pregnant women with COVID-19, 55% had no symptoms on admission, according to a report released this week by the Centers for…
Headline
The Centers for Disease Control and Prevention today updated its testing guidance for SARS-CoV-2, the virus that causes COVID-19. “Due to the significance of…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently posted new and updated COVID-19 resources…
Headline
The Food and Drug Administration this week approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and…